QCM
FLGT icon

Quantinno Capital Management’s Fulgent Genetics FLGT Stock Holding History

Quantinno Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.19M Buy
137,479
+108,519
+375% +$2.36M ﹤0.01% 1565
2025
Q4 		$761K Buy
28,960
+3,147
+12% +$81.6K ﹤0.01% 2008
2025
Q3 		$583K Sell
25,813
-3,604
-12% -$74.2K ﹤0.01% 1877
2025
Q2 		$585K Buy
29,417
+14,480
+97% +$282K ﹤0.01% 1562
2025
Q1 		$252K Buy
14,937
+1,858
+14% +$31.6K ﹤0.01% 1720
2024
Q4 		$242K Buy
+13,079
New +$255K ﹤0.01% 1471

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Quantinno Capital Management's FLGT Position: Q1 2026 in Review

Quantinno Capital Management increased its Fulgent Genetics (FLGT) stake by 375% in Q1 2026, buying an estimated $2.36M and bringing the position to 137,479 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1565.

Quantinno Capital Management first reported a position in FLGT in Q4 2024 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Quantinno Capital Management held 137,479 shares of Fulgent Genetics worth $2.19M as of Q1 2026.
  • Quantinno Capital Management bought 108,519 Fulgent Genetics shares in Q1 2026, an estimated $2.36M.
  • Fulgent Genetics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #1565 holding.
  • Quantinno Capital Management first reported a position in Fulgent Genetics in Q4 2024 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.